|
|
|
NAFLD
http://www.ncbi.nlm.nih.gov/pubmed/25771388
Janczyk W, Lebensztejn D, Wierzbicka-Rucińska A, Mazur A, Neuhoff-Murawska J, Matusik P, Socha P. Omega-3 Fatty acids therapy in children with nonalcoholicFatty liver disease: a randomized controlled trial. J Pediatr. 2015 Jun;166(6):1358-1363.
Abstract
OBJECTIVE:
To evaluate the efficacy and safety of omega-3 fatty acid supplementation in children with nonalcoholic fatty liver disease(NAFLD).
STUDY DESIGN:
https://pubmed.ncbi.nlm.nih.gov/32145139/ NAFLD
BJOG.2020 Sep;127(10):1200-1209.
Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study
A Cantoral 1, A Montoya 1, L Luna-Villa 1, E A Roldán-Valadez 2 3, M Hernández-Ávila 4, D Kershenobich 5, W Perng 6, K E Peterson 7 8 9, H Hu 9 10, J A Rivera 1, M M Téllez-Rojo 1
PMID: 32145139
Abstract
Objective: To examine the associations of maternal and child overweight status across multiple time-points with liver fat content in the offspring during young adulthood.
Design: Cohort study.
Setting: ELEMENT Cohort in Mexico City.
Population: Pregnant women with singleton births (n = 97).
https://www.ncbi.nlm.nih.gov/pubmed/30038464 NAFLD
World J Gastroenterol. 2018 Jul 21;24(27):2974-2983. doi: 10.3748/wjg.v24.i27.2974.Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".Fang YL1, Chen H2, Wang CL1, Liang L3.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/30551665 NAFLD
Children (Basel). 2018 Dec 13;5(12). pii: E169. doi: 10.3390/children5120169.
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease.
Alfani R1,2, Vassallo E3,4, De Anseris AG5, Nazzaro L6, D'Acunzo I7,8, Porfito C9,10, Mandato C11, Vajro P12,13,14,15.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/29471012 NAFLD
J Hepatol. 2018 Feb 19. pii: S0168-8278(18)30123-5. doi: 10.1016/j.jhep.2018.02.006. [Epub ahead of print]
.Hegarty R, Deheragoda M, Fitzpatrick E, Dhawan A.
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/27380600
Putignani L, Alisi A, Nobili V. J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S6-8. doi: 10.1097/MPG.0000000000001220
Abstract
PURPOSE OF REVIEW:
Clinical evidence of the use of probiotics in pediatric NAFLD, framed within gut microbiota response, is herein discussed.
RECENT FINDINGS:
The assistance of a new microbiological approach in probiotics' design is playing a central role in NAFLD clinical management. Experimental studies demonstrated the effect of gut microbiota manipulation in NAFLD and recent clinical evidence reported their beneficial effect in pediatric patients.
SUMMARY:
https://www.ncbi.nlm.nih.gov/pubmed/29095346 NAFLD
J Pediatr Gastroenterol Nutr. 2017 Oct 31. doi: 10.1097/MPG.0000000000001823. [Epub ahead of print]
Pediatric Non-alcoholic Fatty Liver Disease: Current Thinking. Nobili V, Socha P.
Abstract
https://pubmed.ncbi.nlm.nih.gov/33081177/ NAFLD
Review
Nutrients. 2020 Oct 16;12(10):3166.
doi: 10.3390/nu12103166.
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Ashok Mandala 1, Rachel C Janssen 1, Sirish Palle 2, Kevin R Short 1 3 4, Jacob E Friedman 1 3 4
Abstract
https://pubmed.ncbi.nlm.nih.gov/33230078/ NAFLD
J Pediatr Gastroenterol Nutr. 2020 Nov 20.
doi: 10.1097/MPG.0000000000002991.Online ahead of print.
Performance Characteristics, Intra- & Inter-Operator Agreement of Transient Elastography in Pediatric NAFLD
Chetan Mandelia 1 2, Mohammad Nasser Kabbany 1, Sarah Worley 3, Praveen Kumar Conjeevaram Selvakumar 1 4
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/26252921
.NAFLD
Anderson EL, Fraser A, Howe LD, Callaway MP, Sattar N, Day C, Tilling K, Lawlor DA. Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr. 2016 Jan; 62(1):110-7.
Abstract
OBJECTIVES:
The aim of the present study was to assess whether objectively measured physical activity at mean ages 12 and 14 years are prospectively associated with ultrasound scan liver fat and stiffness (alanine aminotransferase, aspartate aminotransferase [AST], and γ-glutamyl transferase [GGT]) assessed at mean age 17.8 years.
METHODS:
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
